Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease

Liver International

Volumn 33, Issue 1, 2013, Pages 79-85

  Alkhouri, Naim ^a   Sedki, Emad ^b   Alisi, Anna ^c   Lopez, Rocio ^a   Pinzani, Massimo ^d   Feldstein, Ariel E ^e   Nobili, Valerio ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FAIRVIEW HOSPITAL   (United States)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Children; Fibrosis; Liver biopsy; Nonalcoholic fatty liver disease; Noninvasive

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; DIABETES MELLITUS; ELASTOGRAPHY; FEMALE; HEPATITIS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONALCOHOLIC FATTY LIVER; PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE FIBROSIS INDEX; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; THROMBOCYTE COUNT; TRANSIENT ELASTOGRAPHY; WAIST CIRCUMFERENCE;

AGE FACTORS; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; CHILD; DISEASE PROGRESSION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LINEAR MODELS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84870843520     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12024     Document Type: Article

References (36)

1. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-63.
2. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-93.
3. Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005; 17: 636-41.
4. Reilly JJ. Obesity in childhood and adolescence: evidence based clinical and public health perspectives. Postgrad Med J 2006; 82: 429-37.
5. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
6. Angulo P. Nonalcoholic fatty liver disease. The New England Journal of Medicine 2002; 346: 1221-31.
7. Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (Baltimore, MD) 2006; 44: 865-73.
8. Kinugasa A, Tsunamoto K, Furukawa N, et al. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3: 408-14.
9. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58: 1538-44.
10. Jankowska I, Socha P, Pawlowska J, et al. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. Pediatr Transplant 2007; 11: 796-8.
11. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology(Baltimore, MD) 2006; 44: 458-65.
12. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, MD) 2005; 41: 1313-21.
13. Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 2008; 28: 386-95.
14. Lebensztejn DM, Kaczmarski M, Sobaniec-Lotowska M, et al. Blind liver biopsy in children-diagnostic significance and complications in authors' own material. Med Sci Monit 2000; 6: 1155-8.
15. Adams L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology (Baltimore, MD) 2010; 51: 370-2.
16. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology(Baltimore, MD) 2007; 45: 846-54.
17. Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology (Baltimore, MD) 2008; 47: 455-60.
18. Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterology 2006; 6: 6.
19. Nobili V, Alisi A, Vania A, et al. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Medicine 2009; 7: 21.
20. Nobili V, Vizzutti F, Arena U, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 2008; 48: 442-8.
21. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Advance Data 2000; 314: 1-27.
22. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ(Clinical Research Ed) 2000; 320: 1240-3.
23. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290-6.
24. Fernandez JR, Redden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. The Journal of Pediatrics 2004; 145: 439-44.
25. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 525-84.
26. Report of the Second Task Force on Blood Pressure Control in Children. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79:1-25.
27. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
28. Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology(Baltimore, MD) 2011; 54: 344-53.
29. Molleston JP, White F, Teckman J, et al. Obese children with steatohepatitis can develop cirrhosis in childhood. The American Journal of Gastroenterology 2002; 97: 2460-2.
30. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology(Baltimore, MD) 2010; 51: 373-5.
31. Pariente D, Franchi-Abella S. Paediatric chronic liver diseases: how to investigate and follow up? Role of imaging in the diagnosis of fibrosis Pediatr Radiol 2010; 40: 906-19.
32. Nobili V, Monti L, Alisi A, et al. Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol 2011; 41: 1232-8.
33. Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008; 57: 1441-7.
34. Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-23.
35. Nobili V, Parkes J, Bottazzo G, et al. Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease. Gastroenterology 2009; 136: 160-7.
36. Alkhouri N, Carter-Kent C, Lopez R, et al. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol 2011; 9: 150-5.